The Week Ahead: Hom...
Health Care: Drugs
PharmAthene Inc. (PIP: AMEX)
$1.75 -0.02 | -1.13%
05/17/13 - 04:05 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -4.92M | -3.80M | -34.85M | -32.28M |
| Operating Gains/Losses | -66.63K | -781.76K | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 898.57K | 1.20M | 1.83M | -4.90M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 251.56K | -1.68M | 1.25M | -1.94M |
| (Decrease) Increase In Other Current Liabilities | -418.08K | 122.41K | -8.51M | 3.29M |
| (Increase) Decrease In Other Working Capital | 867.44K | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 197.75K | -4.62M | 20.19M | 8.73M |
| Net Cash From Continuing Operations | -2.32M | -7.81M | -14.86M | -28.15M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -2.32M | -7.81M | -14.86M | -28.15M |
| Sale of Property, Plant & Equipment | 67.40K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 3.13M | 8.45M |
| Purchases of Property, Plant & Equipment | 0.00 | -71.44K | -374.58K | -1.03M |
| Acquisitions | 0.00 | 0.00 | 0.00 | -7.00M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -8.41M |
| Other Cash from Investing Activities | 0.00 | 1.76M | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 67.40K | 1.69M | 2.76M | -7.99M |
| Issuance of Debt | 1.33M | 0.00 | 0.00 | 10.53M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 38.98K | 5.78M | 21.57M | 4.95M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -11.44K | -9.54M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 2.35M | 0.00 | -100.00K | 12.85M |
| Net Cash From Financing Activities | 3.72M | 5.78M | 21.46M | 18.79M |
| Effect of Exchange Rate Changes | 181.00 | -208.85K | -240.12K | 263.13K |
| Net Change in Cash & Cash Equivalents | 1.46M | -548.56K | 9.11M | -17.08M |
Portfolios with PIP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- UserJSD Holdings
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- ContributorBarron's Insider Purchases ...
Latest PIP Headlines from TheStreet
- TheStreet Ratings Top 10 Rating Changes 03.18.13 | 10:03 am
- PharmAthene Inc. Stock Downgraded (PIP) 03.15.13 | 05:03 am
- 5 Under-$10 Plays Primed to Pop 01.17.13 | 12:01 pm
- PharmAthene Inc. Stock Upgraded (PIP) 11.12.12 | 04:11 am
- 5 Stocks Under $10 Set to Soar 07.12.12 | 12:07 pm
- 7 Stocks Under $10 Streaking Higher 06.07.12 | 04:06 pm
- 5 Stocks Under $10 Set to Trigger Big Moves 01.27.12 | 01:01 pm
- Stock Offerings: Funtalk China 07.20.10 | 10:07 am
- TRW Automotive COO Sells $2.6M Worth 06.01.10 | 09:06 am
- Zanett, Novell: Early Volume Plays 03.22.10 | 09:03 am
Press Releases for PIP
- New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents - PR Newswire 04.17.13 | 10:04 am
- PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013 - PR Newswire 03.12.13 | 09:03 am
- PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013 - PR Newswire 01.17.13 | 09:01 am
- PharmAthene Secures Exclusive License To PER.C6® Cell Line For Commercial Production Of Recombinant Bioscavenger - PR Newswire 01.14.13 | 10:01 am
- PharmAthene Announces Delaware Supreme Court Hears Oral Arguments In Its Litigation With SIGA Technologies - PR Newswire 01.10.13 | 02:01 pm
- PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012 - PR Newswire 11.05.12 | 10:11 am
- PharmAthene Receives FDA Notification On SparVax⢠- PR Newswire 08.10.12 | 09:08 am
- Department Of Defense Exercises Options Under Contract For Nerve Agent Medical Countermeasure Program - PR Newswire 08.09.12 | 10:08 am
- PharmAthene Announces Further Progress In Development Of Its SparVax⢠Anthrax Vaccine Program - PR Newswire 06.14.12 | 11:06 am
- Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling - PR Newswire 06.01.12 | 07:06 am
Partner Headlines for PIP
- Benzinga's Microcap Movers for Friday June 1, 2012 - Benzinga 06.02.12 | 11:06 am
- Pip Pip Hooray - Benzinga 01.12.12 | 01:01 pm
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Analyzing Wednesday's Noteworthy Insider Buys And Sells - Seeking Alpha 01.05.12 | 08:01 am
- Buy And Sell Ideas From Yesterday's News Movers - Seeking Alpha 09.30.11 | 09:09 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- Star Scientific Just Announced They Cured Alzheimer's Disease and Nobody Cares - Seeking Alpha 03.01.11 | 08:03 am
- PharmAthene Beats, But Comes Short on Revenue - Analyst Blog - Zacks 11.11.10 | 07:11 pm
- PIP Continues Like A Runaway Freight Train (PIP) - Benzinga 10.18.10 | 01:10 pm
